along with phenelzine and tranylcypromine it is one of only three classical maois still available for clinical use in the treatment of psychiatric disorders in the united states though it is not as commonly employed in comparison to the others isocarboxazid is primarily used to treat mood and anxiety disorders it has also been investigated in the treatment of parkinson s disease and other dementia related disorders isocarboxazid as well as other maois increase the levels of the monoamine neurotransmitters serotonin dopamine and norepinephrine in the brain classical maois including isocarboxazid are used only very rarely due to prominent food and drug interactions and have been largely superseded by newer antidepressants such as the selective serotonin reuptake inhibitors ssris the cause of the interactions is because maois inhibit the metabolism of dietary amines e g tyramine and the monoamine neurotransmitters in combination with other drugs that increase the levels of the monoamine neurotransmitters such as the ssris or with certain foods high in dietary amines such as aged cheeses maois can produce dangerous elevations of monoamine neurotransmitters resulting in potentially life threatening syndromes such as hypertensive crisis and serotonin syndrome